Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Medtronic
Harvard Business School
Dow
Merck

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rufinamide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

rufinamide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc BANZEL rufinamide SUSPENSION;ORAL 201367 NDA Eisai Inc. 62856-584-46 1 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. 62856-582-04 4 TABLET, FILM COATED in 1 BOTTLE (62856-582-04)
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. 62856-582-52 120 TABLET, FILM COATED in 1 BOTTLE (62856-582-52)
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. 62856-583-14 14 TABLET, FILM COATED in 1 BOTTLE (62856-583-14)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Express Scripts
Harvard Business School
Moodys
McKinsey